Journal of Clinical Medicine (Apr 2024)

Exploring Chronic Hypocalcemia: Insights into Autoimmune Polyglandular Syndrome Type 1—A Case Study and Literature Review

  • Giorgiana-Flavia Brad,
  • Delia-Maria Nicoară,
  • Alexandra-Cristina Scutca,
  • Meda-Ada Bugi,
  • Raluca Asproniu,
  • Laura-Gratiela Olariu,
  • Iulius Jugănaru,
  • Lucian-Ioan Cristun,
  • Otilia Mărginean

DOI
https://doi.org/10.3390/jcm13082368
Journal volume & issue
Vol. 13, no. 8
p. 2368

Abstract

Read online

Hypocalcemia is a common occurrence in pediatric patients, attributed to various causes and presenting with diverse clinical manifestations. A prompt evaluation is necessary to determine its underlying cause, whether it presents acutely or chronically, and to tailor treatment based on its severity. Among the potential causes of chronic hypocalcemia, primary hypoparathyroidism stands out. The case of a seven-year-old male patient with hypocalcemia reported in this article serves as an illustration, wherein targeted next-generation sequencing revealed a homozygous p.R257X mutation in the AIRE gene, indicative of autoimmune polyendocrine syndrome type 1 (APS-1). It poses challenges due to its multisystemic nature and involvement of specific autoantibodies, often leading to underdiagnosis, owing to its rarity, varied manifestations, and incomplete penetrance. A comprehensive review of the APS-1 literature was conducted to provide insights into the clinical manifestations, genetic spectrum, potential immunological mechanisms, and current medical strategies. Additionally, the recognition of AIRE gene mutations is crucial for facilitating genetic diagnosis, prognosis, and potential treatment strategies for APS-1. The management of such cases involves individualized approaches to treatment, regular monitoring, medication adjustments, and the early identification of associated conditions.

Keywords